When Will Headspace IPO? Sword Health Is Buying It for $300M

Segmara Pro posts a weekly IPO brief in the members forum; $15 once for 30 days (plus any applicable tax). No automatic renewal.

By Segmara Research · Published September 27, 2026

As of September 27, 2026, no S-1 or F-1 registration statement exists for Headspace on SEC EDGAR, the U.S. Securities and Exchange Commission's public filing system for domestic listings; the company has instead agreed to be acquired rather than pursue a public listing. PitchBook had named Headspace, alongside Spring Health, as a potential IPO candidate, according to a report by Behavioral Health Business on August 25, 2026, but that framing was overtaken when Sword Health's acquisition of Headspace emerged; regulatory documents cited in that report set the deal's effective date as September 14, 2026. Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million, well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, and that the deal is expected to close before the fourth quarter of 2026. Track SEC EDGAR and the companies' own statements directly, not secondary-market rumors.

Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases. Nothing here is investment advice.

Key points

An acquisition, not a listing

Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million. The deal is expected to close before the fourth quarter of 2026, according to the same report.

An acquisition ends the path to a public listing under Headspace's own name. No S-1 or F-1 registration statement has been filed for Headspace on SEC EDGAR, consistent with the company pursuing a sale rather than a public listing.

From $3 billion to roughly $300 million

The roughly $300 million price is well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, per the September 16, 2026 Yahoo Finance report citing Bloomberg.

The report did not attribute the gap to a single cause, and Segmara has no additional verified detail on what drove the decline between 2021 and the 2026 deal.

The IPO candidacy that came before the deal

Before Sword Health's acquisition emerged, PitchBook had pegged Headspace, alongside Spring Health, as a potential IPO candidate, Behavioral Health Business reported on August 25, 2026.

That same report cited regulatory documents setting the deal's effective date as September 14, 2026, days before the acquisition was reported publicly.

AI-ready data summary

A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.

Metric	Value	Context
Canonical route	/blog/when-will-headspace-ipo	Stable URL path for AI and search extraction.
Article title	When Will Headspace IPO? Sword Health Is Buying It for $300M	Main page topic.
Attached public sources	2	Number of citation links rendered at the bottom of the article.
Segmara listed companies	51	Live private-company listings in the public catalogue.
Priced listings	37	Catalogue listings with visible indicative or direct marks.
Listings without an indicative price	14	Catalogue listings where a public price is intentionally not invented.

Data fingerprint chart

Visible pricing coverage72%

37 of 51 listings show a mark

Stage	Timing	Price / valuation signal	Interpretation

Chart metric	Score	Interpretation
Visible pricing coverage	72 / 100	37 of 51 listings show a mark

Analytical lens

Search intent

Searches like 'When Will Headspace IPO? Sword Health Is Buying It for $300M' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.

What counts as a listing step

For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.

Segmara role

Segmara is an independent research site. It does not sell, broker, or arrange share purchases, and nothing on this page is investment advice.

How a company reaches a US listing

The SEC filing trail

DraftThe company can first submit a draft registration statement (DRS) for confidential SEC review.

S-1 or F-1The registration statement goes public on SEC EDGAR: Form S-1, or Form F-1 for many foreign companies. A company that used a draft must file publicly at least 15 days before its roadshow.

AmendmentsS-1/A or F-1/A amendments answer SEC comments, and one of them adds the expected price range.

PricingOnce the SEC declares the registration effective, the company sets the price with its underwriters and files the final prospectus, usually a 424B4.

First tradeThe shares start trading on the exchange named in the prospectus, such as Nasdaq or the NYSE.

Sources: SEC, March 3, 2025 · Investor.gov, October 14, 2022 · Regulation S-K Item 501 · SEC Form F-1.

Headspace on SEC EDGAR

Headspace is not on Segmara Pro's EDGAR alert list, so no alert is posted for its filings. To look for one, search its name with EDGAR full-text search. Segmara Pro's weekly IPO brief, posted in the members forum, covers filings and pricing across the IPO calendar.

Free IPO calendar · What Segmara Pro includes

Key takeaways

Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace in an all-cash deal valued at roughly $300 million -- an acquisition, not an IPO, and one priced well below Headspace's prior valuation.
That price is a fraction of the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health, according to the same September 16, 2026 report.
Before the acquisition emerged, PitchBook had pegged Headspace, alongside Spring Health, as a potential IPO candidate, Behavioral Health Business reported on August 25, 2026, citing regulatory documents that set the deal's effective date as September 14, 2026.

Risk notes

Rumor risk: unofficial dates, valuations, or funding details circulating on social media or forums are frequently wrong or outdated and should not be treated as confirmation of anything.
Illiquidity risk: any private-market interest, indicative marks, or pre-IPO share arrangements in a company that has not listed can be difficult to exit and may not reflect a tradable price.
Timing risk: a company can pause, restart, or abandon IPO preparation at any stage, including after a confidential or public filing, so no step before pricing guarantees a listing.

Public source links

SEGMARA PRO

Get the weekly IPO Pipeline Brief

Free: every article, the IPO calendar and the weekly IPOs page. Segmara Pro posts a weekly IPO brief in the members forum. 7-day free trial, then $15 a month (plus any applicable tax). Research only, no share sales.

Get Segmara Pro

Read a free issue See the IPO calendar

Questions

Can retail investors track private-company shares on Segmara?

Yes. The free pre-IPO tracker sends indicative marks by email, with no card and no documents. Segmara does not sell, broker, or arrange share purchases.

Why was this market historically hard for retail investors to reach?

Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes research simpler: anyone can follow named private companies for free, by email.

What is the easiest next step?

Open the free pre-IPO tracker first, email only. The IPO calendar is free, and Segmara Pro adds a weekly IPO brief.

Has Headspace confirmed an IPO date?

No. Headspace has not filed an S-1 or F-1 registration statement with the SEC on EDGAR, and no IPO date exists to confirm. Yahoo Finance, citing Bloomberg, reported on September 16, 2026 that Sword Health agreed to acquire Headspace instead, in an all-cash deal valued at roughly $300 million.

Why was Headspace considered an IPO candidate?

PitchBook had named Headspace, alongside Spring Health, as a potential IPO candidate, according to a report by Behavioral Health Business on August 25, 2026, before the Sword Health acquisition emerged. That report cited regulatory documents setting the deal's effective date as September 14, 2026.

What is Headspace worth in the Sword Health deal?

Roughly $300 million, in an all-cash transaction, according to the September 16, 2026 Yahoo Finance report citing Bloomberg. That is well below the $3 billion valuation Headspace reached at its October 2021 merger with Ginger Health.

Can I buy Headspace shares before the IPO?

There is no IPO to buy into. Headspace is being acquired by Sword Health in an all-cash deal, not going public, and Segmara does not sell, broker, or arrange purchases of Headspace shares.

Next step

Track private-market prices free.

If this article helped explain Headspace, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account.

Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases.

Get the free tracker

See the free IPO calendar